About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
Follow Us
Secure Payments
|
|
|
| Previous Close | $56.01 | Open | $56.04 |
| Volume | 326.9K | Market Cap | 846.24M |
| Yield | Last Dividend |
| OptimizeRx Does Earnings Surprise Histor... | 02/23/21 |
| OptimizeRx announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by??? | |
| OptimizeRx to Present at the H.C. Wainwr... | 01/06/21 |
| ROCHESTER, Mich., Jan. 06, 2021 (GLOBE NEWSWIRE) ??? OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science ... | |
| OptimizeRx Partners with Komodo Health t... | 12/07/20 |
| ROCHESTER, Mich., Dec. 07, 2020 (GLOBE NEWSWIRE) ??? OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science ... | |
| OptimizeRx Sets Third Quarter 2020 Confe... | 10/26/20 |
| Share this Stock Information ROCHESTER, Mich., Oct. 26, 2020 (GLOBE NEWSWIRE) ??? OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital healt... | |
| FleetCor Technologies (NYSE:FLT) versus ... | 10/23/20 |
| FleetCor Technologies (NYSE:FLT) and OptimizeRx (NASDAQ:OPRX) are both business services companies, but which is the superior stock? We will compare t... | |
| OptimizeRx Sets Second Quarter 2020 Conf... | 07/23/20 |
| ROCHESTER, Mich., July 23, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science??... | |
| OptimizeRx EPS misses by $0.04, misses o... | 02/27/20 |
| OptimizeRx (NASDAQ:OPRX): Q4 Non-GAAP EPS of -$0.03 misses by $0.04; GAAP EPS of -$0.14 misses by $0.03. Revenue of $7.38M (+12.2% Y/Y) misses by $0.1... | |
| Has OptimizeRx (OPRX) Outpaced Other Com... | 08/07/19 |
| Is (OPRX) Outperforming Other Computer and Technology Stocks This Year? | |
| OptimizeRx (OPRX) to Report Q2 Earnings:... | 08/02/19 |
| OptimizeRx's (OPRX) second-quarter 2019 results are likely to benefit from increased sales of core financial and brand messaging products. | |
| OptimizeRx (OPRX) Gains As Market Dips: ... | 07/31/19 |
| OptimizeRx (OPRX) closed the most recent trading day at $15.09, moving +0.8% from the previous trading session. | |
| OptimizeRx (OPRX) Reports Next Week: Wal... | 07/31/19 |
| OptimizeRx (OPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared wit... | |
| OptimizeRx (OPRX) Dips More Than Broader... | 07/19/19 |
| In the latest trading session, OptimizeRx (OPRX) closed at $15, marking a -0.73% move from the previous day. | |
| S, CMCM and QD among tech movers | 05/20/19 |
| No summary available. | |
| OptimizeRx Corporation (OPRX) Shares Mar... | 05/20/19 |
| As of late, it has definitely been a great time to be an investor in OptimizeRx Corporation (OPRX). | |
| OptimizeRx Corporation's (OPRX) CEO Will... | 05/11/19 |
| No summary available. | |
| CNDT, ROKU, STMP, and CTRL among midday ... | 05/09/19 |
| No summary available. | |
| OptimizeRx beats by $0.04, beats on reve... | 05/08/19 |
| No summary available. | |
| A 68% Chance Of 100% Gain Was Present In... | 03/25/19 |
| No summary available. | |
| OptimizeRx's (OPRX) CEO William Febbo on... | 02/27/19 |
| No summary available. | |
| OptimizeRx +20% amid record revenues, gu... | 02/26/19 |
| No summary available. | |
| OptimizeRx EPS in-line, beats on revenue | 02/26/19 |
| No summary available. | |
| SFUN, VERI and MTLS among tech movers | 01/10/19 |
| No summary available. | |
| Buy rating | 02/25/21 |
| Roth Capital maintains Buy rating and raises Price Target from $70.00 to $85.00 | |
| Buy rating | 01/08/21 |
| Roth Capital maintains Buy rating and raises Price Target from $40.00 to $70.00 | |
| Date | 2021-02-24 (AMC) | Est. (EPS/Rev.) | $0.15/ 16.02M |
| Actual (EPS/Rev.) | $0.16/ $16.43 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| High Growth Stocks- Long only | Srini Donapati | 73.00 % | Follow |
| FEAT. MARVIN GAYE | JOHN KROLIKOWSKI JR | 61.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.